Consultant clinical oncologist
Shahreen Ahmad qualified at University College London (University of London). She trained in clinical oncology at St Bartholomew’s Hospital and Guy's and St Thomas'.
Shahreen treats solid tumours using chemotherapy, radiotherapy, and biological therapies.
She has been involved in the implementation of the latest radiotherapy techniques in lung cancer treatment at Guy’s and St Thomas’, and is the lead cancer clinician for stereoablative radiotherapy (SABR).
Shahreen is lung cancer tumour working group lead for the network and is directorate clinical lead for the cancer information solution (CIS) system currently being implemented in the oncology and haematology departments and Guy’s and St Thomas’.
Education and training
- Membership of the royal college of surgeons (MRCS)
- Fellowship of the royal college of physicians (FRCP)
- Doctor of medicine (research) (MD (res))
- Functional cancer imaging
- Stereoablative radiotherapy (SABR)
Last updated: November 2022